Vicor Corporation Common Stock (VICR) Stock Price Today
Drone defense market to hit $18.19B by 2030 with 30.6% CAGR amid rising security threats
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
SK Hynix Q3 operating profit soars 632% on booming AI chip demand, beating estimates.
SK Hynix reported a sharp rise in its third-quarter results, with operating profit surging 632.1% year-over-year to 83.33 trillion won, surpassing analyst expectations. Revenue also jumped 327.9% to 104.62 trillion won, driven by strong demand for hi...
GE Aerospace's post-earnings dip seen as buying chance; Boeing faces tougher recovery after lowering cash flow outlook.
Jim Cramer highlights a buying opportunity in GE Aerospace following its strong Q3 orders despite a stock pullback amid industry concerns over fuel costs and interest rates. GE's commercial aerospace orders surged 58%, pushing backlog to $170 billion...
Lawsuit probes Neogen over veterinary product linked to horse deaths and FDA warning.
Pomerantz LLP is investigating Neogen Corporation after the FDA issued a warning about its veterinary wound care product, Neogen Vet HYCOAT, linked to at least 20 horse deaths due to contamination. The FDA called this the largest number of horse deat...
Kinross Gold faces investigation after lowering 2026-27 production guidance, shares drop 11.6%.
Pomerantz LLP is investigating Kinross Gold Corporation for potential securities fraud following the company's announcement of a 2-3% reduction in its 2026 and 2027 gold production guidance due to operational challenges and extreme weather. This upda...
Pomerantz LLP investigates America’s Car-Mart for alleged securities fraud amid multiple stock drops.
Pomerantz LLP is investigating America’s Car-Mart, Inc. for potential securities fraud and unlawful practices after the company disclosed delayed filings and financial restatements related to loan modifications. The stock experienced significant decl...
Pomerantz LLP investigates ACADIA Pharmaceuticals over potential securities fraud after trial results disappoint investors.
Pomerantz LLP is investigating ACADIA Pharmaceuticals and some of its executives for possible securities fraud following the company's announcement that its drug remlifanserin narrowly missed the primary endpoint in a Phase 2 clinical trial for Alzhe...
Lawsuit probes Rafael Holdings over failed drug trial causing 35% stock drop
Pomerantz LLP is investigating Rafael Holdings for potential securities fraud following the company's announcement that its Phase 3 drug trial for Niemann-Pick Disease Type C did not meet its primary endpoint. The trial results led to a nearly 35% dr...
Law firm investigates Erasca over COO termination and stock drop amid possible securities fraud claims
Pomerantz LLP is investigating Erasca, Inc. following the announced termination of COO Nicholas Chetwyn, which led to a nearly 10% drop in the company's stock price. The investigation focuses on whether Erasca and its officers engaged in securities f...
Law firm investigates Pasqal for possible securities fraud after quantum program exit causes stock drop
Pomerantz LLP is investigating Pasqal Holding SA and some of its officers for potential securities fraud following Pasqal's announcement that it would exit the LSQUARE/PROQCIMA quantum computing program run by France's defense agency. This announceme...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.